Statins and their influence on brain cholesterol

Journal of Clinical Lipidology

Volumn 5, Issue 5, 2011, Pages 373-379

  Cibičková, L'Ubica ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

24S Hydroxycholesterol; Blood brain barrier; Brain cholesterol; Lathosterol; Statins

Indexed keywords

26 HYDROXYCHOLESTEROL; AMYLOID BETA PROTEIN; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LATHOSTEROL; MEVINOLIN; OXYSTEROL; PRAVASTATIN; SIMVASTATIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; HUMAN; HYDROPHILICITY; LIPOPHILICITY; NERVE DEGENERATION; NEURITE; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; BRAIN; CHOLESTEROL; DATABASES, FACTUAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 80053895906     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.06.007     Document Type: Review

References (42)

1. D.L. Sparks Intraneuronal β-amyloid immunoreactivity in the CNS Neurobiol Aging 17 1996 291 299
2. M.P. Murphy, J. Morales, and T.L. Beckett Changes in cognition and amyloid-beta processing with long term cholesterol reduction using atorvastatin in aged dogs J Alzheimers Dis 22 2010 135 150
3. T. Kurata, K. Miyazaki, and M. Kozuki Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phyosphorylated tau in aged APP mice Brain Res 1371 2011 161 170
4. M. Kozuki, T. Kurata, K. Miyazaki, N. Morimoto, Y. Ohta, Y. Ikeda, and K. Abe Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α Brain Res 1388 2011 32 38
5. J.M. Dietschy, and S.D. Turley Cholesterol metabolism in the brain Curr Opin Lipidol 12 2001 105 112 (Pubitemid 32242918)
6. M. Heverin, S. Meaney, D. Lutjohann, U. Diczfalusy, J. Wahren, and I. Bjorkhem Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain J Lipid Res 46 2004 1047 1052
7. V. Leoni, T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Björkhem Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers J Lipid Res 44 2003 793 799 (Pubitemid 37279681)
8. I. Bjorkhem, A. Cedazo-Minguez, V. Leoni, and S. Meaney Oxysterols and neurodegenerative diseases Mol Aspects Med 30 2009 171 179
9. G.P. Eckert, Ch Kirsch, and W.E. Mueller Differential effects of lovastatin treatment on brain cholesterol levels in normal and ApoE-deficient mice NeuroReport 12 2001 883 887 (Pubitemid 32281439)
10. C. Franke, M. Noldner, and R. Abdel-Kader Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment Neurobiol Dis 25 2007 438 445 (Pubitemid 46138047)
11. S.S. Petanceska, S. DeRosa, and V. Olm Statin therapy for Alzheimer's disease. Will it work? J Mol Neurosci 19 2002 155 161 (Pubitemid 35013349)
12. K.M. Thelen, K.M. Rentsch, and U. Gutteck Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not pravastatin J Pharmacol Exp Ther 316 2006 1146 1152 (Pubitemid 43345288)
13. L. Cibickova, R. Hyspler, and S. Micuda The influence of simvastatin, atorvastatin, and high cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain Steroids 74 2009 13 19
14. L. Cibickova, R. Hyspler, and A. Ticha Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin Pharmazie 63 2008 819 822
15. D. Lutjohann, M. Stroick, and T. Bertsch High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs Steroids 69 2004 431 438 (Pubitemid 38829339)
16. S. Locatelli, D. Lutjohann, H.H. Schmidt, C. Otto, U. Beisiegel, and K. von Bergmann Reduction of plasma 24-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain Arch Neurol 59 2002 213 216 (Pubitemid 34240936)
17. M. Simons, F. Schwarzer, D. Lutjohann, K. von Bergmann, K. Beyreuther, and J. Dichgans Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial Ann Neurol 52 2002 346 350 (Pubitemid 35001502)
18. K. Fassbender, M. Stroick, and T. Bertsch Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide Neurology 59 2002 1257 1258 (Pubitemid 35192402)
19. D. Lutjohann, and K. von Bergmann 24-hydroxycholesterol: a marker of brain cholesterol metabolism Pharmacopsychiatry 36 2003 102 106
20. G.L. Vega, M.F. Weiner, and A.M. Lipton Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease Arch Neurol 60 2003 510 515 (Pubitemid 36427965)
21. K.M. Thelen, D. Lutjohann, and R. Vesalainen Effect of pravastatin on plasma sterols and oxysterols in men Eur J Clin Pharmacol 62 2006 9 14 (Pubitemid 43106310)
22. K.M. Thelen, R. Laaksonen, H. Paiva, T. Lehtimaki, and D. Lutjohann High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels J Clin Pharmacol 46 2006 812 816 (Pubitemid 43882805)
23. A. Serrano-Pozo, G.L. Vega, and D. Lütjohann Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers Alzheimer Dis Assoc Disord 24 2010 220 226
24. K. Hoglund, K.M. Thelen, and S. Syversen The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease Dement Geriatr Cogn Disord 19 2005 256 265 (Pubitemid 40663319)
25. J. Koschack, D. Lütjohann, C. Schmidt-Samoa, and E. Irle Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals Neurobiol Aging 30 2009 898 902
26. A. Solomon, V. Leoni, and M. Kivipelto Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease Neurosci Lett 462 2009 89 93
27. A. Corsini, S. Bellosta, R. Baetta, R. Fumagalli, R. Paoletti, and F. Bernini New insights into the pharmacodynamic and pharmacokinetic properties of statins Pharmacol Ther 84 1999 413 428
28. M. Schachter Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update Fund Clin Pharm 19 2004 17 125
29. L.N. Johnson-Anuna, and G.P. Eckert Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex J Pharm Exp Ther 312 2005 786 793 (Pubitemid 40189580)
30. D.L. Sparks, D.J. Connor, P.J. Browne, J.E. Lopez, and M.N. Sabbagh HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier J Nutr Health Aging 6 2002 324 331 (Pubitemid 36118981)
31. C. Serougne, C. Lefevre, and F. Chevallier Cholesterol transfer between brain and plasma in the rat: A model for the turnover of cerebral cholesterol Exp Neurol 51 1976 229 240
32. C. Kirsch, G.P. Eckert, A.R. Koudinov, and W.E. Muller Brain cholesterol, statins and Alzheimer's disease Pharmacophychiatry 36 Suppl 2 2003 113 119
33. A. Saheki, T. Terasaki, I. Tamai, and A. Tsuji In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors Pharm Res 11 1994 305 311 (Pubitemid 24076229)
34. A. Tsui, A. Saheki, I. Tamai, and T. Terasaki Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the blood-brain barrier J Pharmacol Exp Ther 267 1993 1085 1090 (Pubitemid 24068669)
35. H.S. Malhotra, and K.L. Goa Atorvastatin An updated review of its pharmacological properties and use in dyslipidaemia Drugs 61 2001 1835 1881 (Pubitemid 32980510)
36. E.C.M. de Lange, A.G. de Boer, and D.D. Breimer Methodological issues in microdialysis sampling for pharmacokinetic studies Adv Drug Deliv Rev 45 2000 125 148
37. R.E. Botti, J. Triscari, H.Y. Pan, and J. Zayat Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects Clin Neuropharmacol 14 1991 256 261
38. D.L. Sparks, M.N. Sabbagh, and D.J. Connor Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results Arch Neurol 62 2005 753 757 (Pubitemid 40656090)
39. D.L. Sparks, D.J. Connor, M.N. Sabbagh, R.B. Petersen, J. Lopez, and P. Browne Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial Acta Neurol Scand Suppl 185 2006 3 7 (Pubitemid 44015218)
40. B. McGuinness, J. O'Hare, D. Craig, R. Bullock, R. Malouf, and P. Passmore Statins for the treatment of dementia Cochrane Database Syst Rev 8 2010 CD007514
41. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
42. S. Trompet, P. van Vliet, and A.J.M. de Craen Pravastatin and cognitive function in the elderly. Results of the PROSPER study J Neurol 257 2010 85 90